Compare JNJ & C Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JNJ | C |
|---|---|---|
| Founded | 1886 | 1812 |
| Country | United States | United States |
| Employees | N/A | 226000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 542.4B | 220.2B |
| IPO Year | 2003 | N/A |
| Metric | JNJ | C |
|---|---|---|
| Price | $254.84 | $141.21 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 16 |
| Target Price | ★ $238.20 | $134.94 |
| AVG Volume (30 Days) | 7.7M | ★ 9.9M |
| Earning Date | 04-14-2026 | 04-14-2026 |
| Dividend Yield | ★ 2.36% | 1.88% |
| EPS Growth | ★ 90.50 | N/A |
| EPS | ★ 2.14 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.63 | $24.26 |
| Revenue Next Year | $7.43 | $3.63 |
| P/E Ratio | $114.54 | ★ $16.63 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $151.52 | $84.61 |
| 52 Week High | $251.71 | $147.96 |
| Indicator | JNJ | C |
|---|---|---|
| Relative Strength Index (RSI) | 72.20 | 59.41 |
| Support Level | $233.83 | $108.46 |
| Resistance Level | N/A | $147.96 |
| Average True Range (ATR) | 5.13 | 3.31 |
| MACD | 1.78 | 0.18 |
| Stochastic Oscillator | 99.24 | 57.17 |
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Citigroup is a global financial powerhouse that orchestrates the movement of $5 trillion in daily transaction volume, serving as the essential connective tissue for the world's most complex multinational corporations. The firm remains a leader on the global stage, servicing 90% of the Fortune 500 through a proprietary network that includes direct membership to over 270 cash-clearing centers and a footprint that spans 94 countries. After a checkered history operating as an overly complex, disjointed firm, steps have been taken to streamline operations, resulting in organization across five segments: services, markets, banking, wealth, and US personal banking.